Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical CofiledCriticalMitsubishi Gas Chemical Co
Publication of BR112022006132A2publicationCriticalpatent/BR112022006132A2/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Fats And Perfumes
(AREA)
Abstract
COMPOSTO ALDEÍDO E MÉTODO PARA PRODUÇÃO DO MESMO, E COMPOSIÇÃO DE FRAGRÂNCIA. A presente invenção refere-se a um composto aldeído adequado para uma fragrância e um ingrediente de fragrância, ou uma matéria-prima do mesmo, e um método para produzir o composto aldeído, bem como uma composição de fragrância contendo o composto aldeído como ingrediente ativo e uso do composto aldeído como fragrância. Um composto representado pela Fórmula (1): onde na Fórmula (1), R é um átomo de hidrogênio ou um grupo metila.ALDEHYDE COMPOUND AND METHOD FOR PRODUCTION THEREOF, AND FRAGRANCE COMPOSITION. The present invention relates to an aldehyde compound suitable for a fragrance and a fragrance ingredient, or a raw material thereof, and a method of producing the aldehyde compound, as well as a fragrance composition containing the aldehyde compound as an active ingredient. and use of the aldehyde compound as a fragrance. A compound represented by Formula (1): where in Formula (1), R is a hydrogen atom or a methyl group.
BR112022006132A2019-10-172020-10-16
ALDEHYDE COMPOUND AND METHOD FOR PRODUCTION THEREOF, AND FRAGRANCE COMPOSITION
BR112022006132A2
(en)
DERIVATIVES OF 2-CARBOXAMIDE - CICLOAMINO - UREA SPECIFIC, ITS PHARMACUTICALLY ACCEPTABLE SALTS, COMPOSITIONS CONTAINING THEM, PRO-PHARMACES OF THE SAME, PROCESSES FOR PRODUCTION AND APPLICATIONS
POLYMORPHIC FORMS OF COMPOUNDS REPRESENTING A KINASE INHIBITOR CONTAINING THEIR PHARMACEUTICAL COMPOSITION, METHOD FOR PRODUCING THEIR AND THEIR APPLICATION
compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, method for administering an effective amount of a pharmaceutical composition, and tnf-a inhibitor.